Keywords: sucampo, initiates, post-marketing, assessment, amitiza, usa-based, drug

Sucampo initiates post-marketing assessment of Amitiza

Article | 19 March 2007

USA-based drug developer Sucampo Pharmaceuticals says it has initiated two post-approval clinical studies of its Chronic Idiopathic Constipation drug Amitiza ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amitiza

Lubiprostone

Go to drug listing